Keyphrases
Active Regions
14%
Antigen-specific T Cells
100%
Binding Region
14%
CD4+ T Cells
14%
Complex Activation
14%
Convergent Evolution
14%
Cytokine Factors
14%
Deltaretrovirus
14%
Disease Onset
14%
Fusion Peptide
100%
Fusion Protein
42%
Gp41
42%
HIV Fusion
14%
HIV-1 Fusion Peptide
14%
Human Immunodeficiency Virus Type 1 (HIV-1)
28%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
100%
Hyperactivity
28%
Lentivirus
14%
Membrane Binding
14%
Modulatory
14%
Mouse Model
28%
Multiple Sclerosis
14%
Peptide Inhibition
14%
Protein-based
14%
Receptor Complex
28%
Suppression Strategy
14%
T Cell Activation
100%
T Cell Receptor
28%
T Cell Suppression
14%
T Cells
57%
T-cell Modulation
28%
Th2 Response
14%
Transcription Factor
14%
Viral
14%
Viral Fusion Protein
14%
Virus
14%
Immunology and Microbiology
Antigen Specificity
100%
Convergent Evolution
14%
Cytokine
14%
Deltaretrovirus
14%
Gp41
42%
Human Immunodeficiency Virus
28%
Human Immunodeficiency Virus 1
57%
Human T Cell Leukemia Virus
57%
Human T-Lymphotropic Virus 1
100%
Lentivirus
14%
Membrane Binding
14%
Mouse Model
28%
Multiple Sclerosis
14%
T Cell
100%
T Cell Activation
100%
T Cell Receptor
28%
T-Helper Cell
14%
Transcription Factors
14%
Biochemistry, Genetics and Molecular Biology
Antigen Specificity
100%
CD4
9%
Cell Activation
100%
Chimeric Protein
36%
Convergent Evolution
9%
Cytokine
9%
Deltaretrovirus
9%
Gp41
27%
Human Immunodeficiency Virus
18%
Human Immunodeficiency Virus 1
36%
Human T Cell Leukemia Virus
36%
Human T-Lymphotropic Virus 1
100%
Lentivirus
9%
Membrane Binding
9%
Messenger RNA
9%
Mouse Model
18%
T Cell
100%
T Cell Receptor
18%
Transcription Factors
9%
Pharmacology, Toxicology and Pharmaceutical Science
Chimeric Protein
50%
Cytokine
16%
Deltaretrovirus
16%
Disease
16%
HIV
100%
Human T Cell Leukemia Virus
66%
Human T-Lymphotropic Virus 1
100%
Lentivirus
16%
Messenger RNA
16%
Mouse Model
33%
Multiple Sclerosis
16%
T Lymphocyte Receptor
33%
Transcription Factors
16%
Virus Fusion Protein
16%
Neuroscience
CD4
9%
Cell Activation
100%
Chimeric Protein
27%
Human Immunodeficiency Virus
54%
In Vitro
100%
In Vivo
9%
Membrane Binding
9%
Messenger RNA
9%
Multiple Sclerosis
9%
T Cell
100%
T Lymphocyte Receptor
18%
Transcription Factors
9%
Virus Fusion Protein
9%